Bayer and Monsanto
Mac Miller Earlier last week, German pharmaceutical giant, Bayer, ended a multi-month-long pursuit of American agricultural leader, Monsanto. Bayer announced that the $66
[...]
Circa 1930: The NeoLiberal Retreat
Mikal Khoso As the chorus of Neoliberalism quietens, the world enters a period of uncertainty and tension similar to the decade before WWII.
[...]
The Epipen: Raising the Cost to Live
Garry Canepa For millions of Americans with food allergies, a tiny injection of epinephrine could mean the difference between life and death. The
[...]
The Leon Cooperman Insider Trading Case
Dhruv Kumar Insider trading charges were filed against billionaire hedge fund manager Leon Cooperman by the SEC on September 21st. Cooperman is the
[...]
Economic Impact of NC House Bill 2
Mac Miller North Carolina has been in the news as of late because of the strong reaction to a new law signed by
[...]
Will the U.S. Treasury’s New Plans to curb Inversions end M&A Momentum?
Ray Ga Ming Li Since the crumble of the U.S. economy in the 2008 recession, Obama has been pushing for the elimination of
[...]
Tesla Model 3: An Overview
Dhruv Kumar On March 31st the electric car company Tesla motors unveiled its most important car, the Tesla Model 3. With a high
[...]
Why Do We Invest in Gold?
Mac Miller Throughout history, gold has been treated as one of the most valuable resources known to man. Since its discovery, gold has
[...]
Special Report: Imagining a Post-Work World
Mikal Khoso You pull out your phone and swipe right to order a ride. Moments later, a sleek black car pulls up to
[...]
Fintech: The Rising Tide of Investment
Mikal Khoso 2015 saw soaring investment in companies and startups in the financial technology (fintech) space. According to a recent report from KPMG
[...]